Jump to content

List of largest biomedical companies by revenue

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by XyZAn (talk | contribs) at 21:57, 10 August 2020 (→‎Top pharmaceutical companies with revenue greater than $10 billion). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

The following is a list of the top independent pharmaceutical, biotechnology and medical companies ranked by their revenue generated ($10 billion) in the respective financial year, it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.

The change is the companies relative position in this list, compared to their relative position in the prior year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the previous year, red cells indicate those years where there has been a decrease.

Top pharmaceutical companies with revenue greater than $10 billion

Rank Chg Company 2020
USD billions 		2019
USD billions 		2018
USD billions 		2017
USD billions 		2016
USD billions 		2015
USD billions 		2014
USD billions 		2013
USD billions 		2012
USD billions 		2011
USD billions
1 Steady United States Johnson & Johnson
NYSE: JNJ 		39.03 Q2[1] 82.06[2] 81.60[3] 76.50[4] 71.89[5] 70.10[6] 74.30[7] 71.31[8] 67.20[9] 65.00[10]
2 Steady Switzerland Roche
SIX: ROG 		32.13 Q2[11] 63.85[12] 56.86[13] 57.37[14] 50.11[15] 47.70[16] 49.86[17] 48.53[18] 47.80[19] 45.21[20]
3 Increase 1 China Sinopharm
SEHK: 1099 		60.18[21] 48.75[22] 43.63[23] 36.56[24] 32.36[25] 28.32[26] 23.61[27] 19.31[28] 14.46[29]
4 Decrease 1 United States Pfizer
NYSE: PFE 		23.83 Q2[30] 51.75[31] 53.60[32] 52.54[33] 52.82[34] 48.85[35] 49.61[36] 51.58[37] 58.99[38] 65.26[39]
5 Steady Germany Bayer
FWB: BAYN 		26.88 Q2 [40] 48.02 [41] 45.06[42] 37.94[43] 25.27[44] 24.09[45] 25.47[46] 24.17[47] 24.30[48] 23.11[49]
6 Steady Switzerland Novartis
NYSE: NVS 		23.63 Q2[50] 47.45[51] 44.75[52] 49.11[53] 48.52[54] 49.41[55] 58.00[56] 57.36[57] 56.67[58] 58.57[59]
7 Increase 1 United States Merck & Co.
NYSE: MRK 		22.93 Q2[60] 46.84[61] 42.30[62] 40.10[63] 39.80[64] 39.50[65] 42.24[66] 44.03[67] 47.27[68] 48.05[69]
8 Decrease 1 United Kingdom GlaxoSmithKline
LSE: GSK 		21.91 Q2[70] 43.92[71] 43.14[72] 42.05[73] 34.79[74] 29.84[75] 37.96[76] 41.61[77] 39.93[78] 41.39[79]
9 Steady France Sanofi
NYSE: SNY 		20.33 Q2[80] 39.28[81] 39.07[82] 42.91[83] 36.57[84] 36.73[85] 43.07[86] 42.08[87] 46.41[88] 44.34[89]
10 Steady United States AbbVie
NYSE: ABBV 		19.05 Q2[90] 33.27[91] 32.75[92] 28.22[93] 25.56[94] 22.82[95] 19.96[96] 18.79[97] – –
11 Steady United States Abbott Laboratories
Nasdaq: ABT 		15.05 Q2[98] 31.90[99] 30.60[100] 27.39[101] 20.85[102] 20.41[103] 20.25[104] 21.85[105] 39.87[106] 38.85[107]
12 Increase 8 Japan Takeda Pharmaceutical
TYO: 4502 		7.59 Q1[108] 31.17[109] 19.10[110] 16.70[111] 15.96[112] 14.93 16.84 17.36 18.91 17.80
13 Increase 1 United States Bristol-Myers Squibb
Nasdaq: BMY 		20.91 Q2 [113] 26.15[114] 22.56[115] 20.80[116] 19.43[117] 16.56[118] 15.88[119] 16.39[120] 17.62[121] 21.24[122]
14 Decrease 2 United States Thermo Fisher Scientific
NYSE: TMO 		13.15 Q2[123] 25.54[124] 24.36[124] 20.92[125] 18.27[126] 16.97[127] 16.89[128] 13.09[128] 12.51[129] 11.56[129]
15 Increase 1 United KingdomSweden AstraZeneca
LSE: AZN 		12.63 Q2[130] 24.38[131] 22.09[132] 22.47[133] 23.00[134] 24.71[135] 26.10[136] 25.71[137] 27.97[138] 33.59[139]
16 Decrease 3 United States Amgen
Nasdaq: AMGN 		12.37 Q2[140] 23.40[141] 23.70[142] 22.80[143] 22.99[144] 21.66[145] 20.06[146] 18.68[147] 17.30[148] 15.58[149]
17 Decrease 2 United States Gilead Sciences
Nasdaq: GILD 		10.53 Q2[150] 22.45[151] 22.13[152] 25.70[153] 30.39[153] 32.15[153] 24.47[153] 10.80[153] 9.70[153] 8.39[153]
18 Decrease 1 United States Eli Lilly & Co
NYSE: LLY 		11.36 Q2[154] 22.32[155] 21.49[156] 22.90[157] 21.22[158] 20.00[159] 19.62[160] 23.11[161] 22.60[162] 24.29[163]
19 Decrease 1 Germany Boehringer Ingelheim
Private 		19.48[164] 21.67[165] 17.54[166] 16.41[166] 17.70[166] 18.68[166] 18.89[166] 18.34[166]
20 Steady United States GE Healthcare
Subsidiary of General Electric 		19.94[167] 19.78[168] 19.02[169] 18.21[170] 17.64[171] 18.30[172] 18.20[173] 18.29[174]
21 Increase 2 Denmark Novo Nordisk
NYSE: NVO 		10.07 Q2[175] 18.30[176] 16.99[177] 18.77[178] 16.61[179] 16.06[180] 15.83[181] 14.88[182] 13.48[183] 11.56[184]
22 Increase 2 Germany Merck Group
ETR: MRK 		4.86 Q1[185] 18.25[186] 16.48[187] 18.70[188] 16.62[189] 14.25[190] 15.29[191] 14.73[188] 14.36[188] 14.31[188]
23 Decrease 3 United States Danaher Corporation
NYSE: DHR 		4.34 Q1[192] 17.91[193] 19.89[194] 18.33[195] 16.88[196] 20.56[197] 19.91[198] 19.12[199] 18.26[200] 16.09[201]
24 Decrease 2 Israel/United States Teva Pharmaceutical Industries
Nasdaq: TEVA 		8.26 Q2[202] 16.89[203] 18.90[204] 22.40[205] 21.90[206] 20.00[207] 20.27[208] 20.31[209] 18.31[210] 16.12[211]
25 Steady Germany Siemens Healthineers
FWB: SHL 		10.58 Q3[212][213] 16.29[214] 15.44[215] 16.56[216] 14.25[217] 14.06[218]
26 Steady United States Stryker Corporation
NYSE: SYK 		6.35 Q2[219] 14.90[220] 13.60[221] 12.44[221] 11.33[222] 9.95[222] 9.68[223] 9.02[223] 8.66[224] 8.31[224]
27 Steady United States Biogen
Nasdaq: BIIB 		3.53 Q1[225] 14.38[226] 13.45[227] 12.30[228] 11.40[229] 10.80[230] 9.70[231] 6.90[232] 5.50[233] 5.00[234]
28 Steady Japan Astellas Pharma
TYO: 4503 		12.20[235] 12.27[236] 12.07 12.63 11.48 10.49 9.25 8.92 8.78
29 Increase 1 United States Labcorp
NYSE: LH 		5.59 Q2[237] 11.55[238] 11.33[239] 10.31[239] 9.55[239] 8.51[239] 6.01[239] 5.81[240] 5.67[240] 5.54[240]
30 Decrease 1 United States Mylan
Nasdaq: MYL 		5.35 Q2 [241] 11.50 [242] 11.43 [243] 11.91 [243] 11.08 [243] 9.43 [243] 7.72 [243] 6.91 [244] 6.80 [244] 6.13 [244]
31 Steady United States Baxter International
NYSE: BAX 		5.50 Q2[245] 11.36[246] 11.13 [247] 10.56 [247] 10.16 [248] 9.97 [249] 10.72 [250] 14.97 [251] 14.19 [252] 13.89 [252]
32 Steady United States Boston Scientific
NYSE: BSX 		10.65[253] 9.82[253] 9.05[254] 9.08[255] 8.07[256] 7.46[257] 7.14[258] 7.25[259] 7.62[260]

See also

Notes

References

  1. ^ https://www.jnj.com/johnson-johnson-reports-2020-second-quarter-results
  2. ^ "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results: | BioSpace".
  3. ^ "Johnson & Johnson Reports 2018 Fourth-Quarter Results:". Content Lab - U.S.
  4. ^ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  5. ^ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  6. ^ "Johnson & Johnson Reports 2015 Fourth-Quarter Results:". Archived from the original on 2016-02-11. Retrieved 2018-01-28.
  7. ^ "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  8. ^ "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  9. ^ "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results:".
  10. ^ "Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:".
  11. ^ https://www.roche.com/dam/jcr:adb6371d-d47b-40f1-8aa9-3f9ca2bc2a6f/en/hy20e.pdf
  12. ^ https://www.roche.com/dam/jcr:e49f6995-e813-43c1-9302-c9b7d0bddbc8/en/irp200130-a.pdf
  13. ^ https://www.roche.com/dam/jcr:af865dfd-50fb-458b-9cac-34097db9d3ec/en/ar18e.pdf
  14. ^ "Roche reports good results in 2017". www.roche.com.
  15. ^ https://www.roche.com/dam/jcr:ee2f197f-5487-4629-9e28-66b77c9cbbab/en/ar16e.pdf
  16. ^ https://www.roche.com/dam/jcr:9b36e11d-495c-42f5-b757-e80c4e88d793/en/gb15e.pdf
  17. ^ https://www.roche.com/dam/jcr:880b44a1-3fd6-4e66-bf10-f4af1e724d4d/en/gb14e.pdf
  18. ^ https://www.roche.com/dam/jcr:64fd6b2d-1a76-467f-badd-ab94b85b6d70/en/gb13e.pdf
  19. ^ https://www.roche.com/dam/jcr:3e048249-e3ce-4969-a77e-cc90d8f3fa73/en/gb12e.pdf
  20. ^ https://www.roche.com/dam/jcr:52174b39-feab-4210-82f6-9b8786a69ecf/en/gb11e.pdf
  21. ^ http://ir.sinopharmgroup.com.cn/attachment/202004240816014279248723_en.pdf
  22. ^ http://ir.sinopharmgroup.com.cn/attachment/2019042506350100033473013_en.pdf
  23. ^ http://ir.sinopharmgroup.com.cn/attachment/2018042506320200033121116_en.pdf
  24. ^ http://ir.sinopharmgroup.com.cn/attachment/2017042106200200012785604_en.pdf
  25. ^ http://ir.sinopharmgroup.com.cn/attachment/201607131609541765679138_en.PDF
  26. ^ http://ir.sinopharmgroup.com.cn/attachment/2015041006320100032166702_en.pdf
  27. ^ http://ir.sinopharmgroup.com.cn/attachment/20140410061701001886801_en.pdf
  28. ^ http://ir.sinopharmgroup.com.cn/attachment/20130419164701001633683_en.pdf
  29. ^ http://ir.sinopharmgroup.com.cn/attachment/20120420064701001411060_en.pdf
  30. ^ https://www.biospace.com/article/releases/pfizer-reports-second-quarter-2020-results/?s=72
  31. ^ "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS | BioSpace".
  32. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2018/q4/Q4-2018-PFE-Earnings-Release.pdf
  33. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf
  34. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf
  35. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf
  36. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf
  37. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf
  38. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf
  39. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2011/financial2011.pdf
  40. ^ https://www.bayer.com/downloads/bayer-ag-half-year-financial-report-q2-2020.pdfx?forced=true
  41. ^ "Bayer AG Annual Report 2019". www.bayer.com.
  42. ^ "Bayer's Annual Report 2018". www.annualreport2018.bayer.com.
  43. ^ http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf
  44. ^ http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf
  45. ^ http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf
  46. ^ AG, Bayer. "Bayer – Global Home". www.bayer.com.
  47. ^ https://www.bayer.com/en/ar-2013.pdfx
  48. ^ https://www.bayer.com/en/ar-2012.pdfx
  49. ^ https://www.bayer.com/en/ar-2011.pdfx
  50. ^ https://www.novartis.com/sites/www.novartis.com/files/q2-2020-media-release-en.pdf
  51. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2019-media-release-en.pdf
  52. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf
  53. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  54. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf
  55. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf
  56. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf
  57. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf
  58. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf
  59. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2011-en.pdf
  60. ^ https://www.biospace.com/article/releases/-merck-announces-second-quarter-2020-financial-results/?s=72
  61. ^ https://www.biospace.com/article/releases/merck-announces-fourth-quarter-and-full-year-2019-financial-results/?s=72
  62. ^ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  63. ^ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket".
  64. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf
  65. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf
  66. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf
  67. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf
  68. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf
  69. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2011/annual/form-10-k-2011.pdf
  70. ^ https://www.gsk.com/media/6064/q2-2020-results-announcement.pdf
  71. ^ https://www.gsk.com/media/5820/fy-2019-results-announcement.pdf
  72. ^ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
  73. ^ https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf
  74. ^ https://www.gsk.com/media/3609/annual-report-2016.pdf
  75. ^ https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf
  76. ^ https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf
  77. ^ https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf
  78. ^ https://www.gsk.com/media/2694/annual-report-2012.pdf
  79. ^ https://www.gsk.com/media/2696/annual-report-2011.pdf
  80. ^ https://www.biospace.com/article/releases/sanofi-h1-2020-business-eps-1-growth-of-9-2-percent-2-driven-by-transformation/?s=72
  81. ^ https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q4-results-2019
  82. ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560
  83. ^ https://www.sanofi.com/media/Project/One-Sanofi-Web/sanofi-com/en/investors/docs/press-releases/Press_release_Q4_FY_2017.pdf
  84. ^ https://en.sanofi.com/Images/49288_20-F_2016.pdf
  85. ^ https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf
  86. ^ https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf
  87. ^ https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf
  88. ^ https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf
  89. ^ https://en.sanofi.com/Images/29804_20F_2011.pdf
  90. ^ https://www.biospace.com/article/releases/abbvie-reports-second-quarter-2020-financial-results/?s=72
  91. ^ https://www.biospace.com/article/releases/abbvie-reports-full-year-and-fourth-quarter-2019-financial-results/?s=72
  92. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  93. ^ "Financial Release - AbbVie". investors.abbvie.com.
  94. ^ "Financial Release - AbbVie". investors.abbvie.com.
  95. ^ "Financial Release - AbbVie". investors.abbvie.com.
  96. ^ "Financial Release - AbbVie". investors.abbvie.com.
  97. ^ "Financial Release - AbbVie". investors.abbvie.com.
  98. ^ https://www.abbottinvestor.com/node/32476/html#StatementofEarnings_149166
  99. ^ https://www.biospace.com/article/releases/abbott-reports-fourth-quarter-2019-results-announces-strong-forecast-for-2020/?s=72
  100. ^ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  101. ^ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  102. ^ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  103. ^ "Abbott Reports Fourth-Quarter 2015 Results".
  104. ^ "Abbott Reports Fourth-Quarter 2014 Results".
  105. ^ Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
  106. ^ "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
  107. ^ "Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings - FiercePharma". www.fiercepharma.com.
  108. ^ https://www.biospace.com/article/releases/takeda-announces-fy2020-q1-results-confirms-management-guidance-and-amp-raises-reported-operating-profit-and-reported-net-profit-for-the-full-year/?s=72
  109. ^ https://www.takeda.com/newsroom/newsreleases/2020/takeda-accelerates-transformation-solid-fy2019-results-confidence-in-fy2020-growth-momentum/
  110. ^ https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-fy2018-full-year-results-and-issues-fy2019-guidance/
  111. ^ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  112. ^ "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report" (PDF).{{cite web}}: CS1 maint: url-status (link)
  113. ^ https://www.biospace.com/article/releases/bristol-myers-squibb-reports-second-quarter-2020-financial-results/?s=72
  114. ^ https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79
  115. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  116. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  117. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  118. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  119. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
  120. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
  121. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf
  122. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/BristolMyersSquibb-2011-AnnualReport.pdf
  123. ^ https://www.prnewswire.com/news-releases/thermo-fisher-scientific-reports-second-quarter-2020-results-301097477.html
  124. ^ a b https://www.biospace.com/article/releases/thermo-fisher-scientific-reports-fourth-quarter-and-full-year-2019-results/?s=72
  125. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2018/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2017-Results/default.aspx
  126. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2017/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2016-Results/default.aspx
  127. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2016/Thermo-Fisher-Scientific-Reports-Record-Fourth-Quarter-and-Full-Year-2015-Results/default.aspx
  128. ^ a b https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2015/Thermo-Fisher-Scientific-Reports-Strong-Fourth-Quarter-and-Full-Year-2014-Results/default.aspx
  129. ^ a b http://thermofisher.mediaroom.com/2013-01-31-Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2012-Results
  130. ^ https://www.astrazeneca.com/content/dam/az/PDF/2020/h1-2020/H1_2020_results_announcement.pdf
  131. ^ https://www.astrazeneca.com/content/dam/az/PDF/2019/full-year/Full-year_and_Q4_2019_results_announcement.pdf
  132. ^ https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf
  133. ^ https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf
  134. ^ https://www.astrazeneca.com/content/dam/az/PDF/Full_year_and_q4_2016_results/Full_Year_and_Q4_2016_Results_announcement.pdf
  135. ^ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  136. ^ "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
  137. ^ "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
  138. ^ "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
  139. ^ "AstraZeneca PLC Fourth quarter and full year results 2011". www.astrazeneca.com.
  140. ^ https://www.biospace.com/article/releases/amgen-reports-second-quarter-2020-financial-results/?s=72
  141. ^ https://www.biospace.com/article/releases/amgen-reports-fourth-quarter-and-full-year-2019-financial-results/?s=72
  142. ^ "Amgen - Investors - Press Release". investors.amgen.com.
  143. ^ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  144. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1
  145. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1
  146. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1
  147. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1
  148. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1
  149. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTM0MzEzfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  150. ^ https://www.biospace.com/article/releases/gilead-sciences-announces-second-quarter-and-first-half-2020-financial-results/?s=72
  151. ^ https://www.biospace.com/article/releases/gilead-sciences-announces-fourth-quarter-and-full-year-2019-financial-results/?s=72
  152. ^ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  153. ^ a b c d e f g "Investor Overview". Gilead Sciences.
  154. ^ https://www.biospace.com/article/releases/lilly-reports-second-quarter-financial-results-raises-eps-guidance/?s=72
  155. ^ https://www.biospace.com/article/releases/lilly-reports-strong-fourth-quarter-and-full-year-2019-financial-results-updates-2020-guidance-for-pending-dermira-acquisition/?s=72
  156. ^ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  157. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x970018/15B962F7-AF5A-4FFA-BE13-42206D3A0820/Q4_2017_PressRelease.pdf
  158. ^ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  159. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x871993/5BE670A3-2B82-4876-8471-CA6BC3BD49F8/Lilly_Q4_2015_Press_Release.pdf
  160. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x806120/8637C572-31C4-402E-A179-5E107A5366B2/Q414_Lilly_Sales_and_Earnings_Press_Release.pdf
  161. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x721860/2DB60538-94FE-4E96-98D2-DA72CC301EA0/Q413%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  162. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x631117/85679233-E13C-4FE7-9431-E97EFFDA6D5D/Q412%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  163. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x538046/24A15621-7850-45EC-8E20-30535C3D9FC9/Q411_Lilly_Sales_and_Earnings_Press_Release.pdf
  164. ^ http://annualreport.boehringer-ingelheim.com/fileadmin/Download-Center/BI_GB_18_en_ohne_Unterschriften.pdf
  165. ^ "Boehringer Ingelheim 2017 Annual Report" (PDF). www.boehringer-ingelheim.com.
  166. ^ a b c d e f "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
  167. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  168. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  169. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  170. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  171. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  172. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  173. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  174. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  175. ^ https://investor.novonordisk.com/q2-2020-presentation/?page=31
  176. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2020/20200502_Financial%20statement%20Q4%202019_UK.pdf
  177. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2019/20190201_Financial%20statement%20Q4%202018_UK.pdf
  178. ^ "News details". www.novonordisk.com.
  179. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2017/20170202_Financial%20statement_FY%202016_UK.pdf
  180. ^ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  181. ^ Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
  182. ^ Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
  183. ^ Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
  184. ^ http://www.novonordisk.co.uk/content/dam/Denmark/HQ/Commons/documents/Novo-Nordisk-AR-2011-en.pdf
  185. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2020-q1/en/2020-Q1-Financial-Statement-EN.pdf
  186. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2019-q4/en/2019-Q4-Report-EN.pdf
  187. ^ "Q4/FY Results of 2018 - News - Merck KGaA, Darmstadt, Germany". www.emdgroup.com.
  188. ^ a b c d "404 page - EMD Group". www.emdgroup.com. {{cite web}}: Cite uses generic title (help)
  189. ^ http://ar2016.merckgroup.com/sites/default/files/downloads/en/merck_annual_report_2016.pdf
  190. ^ http://ar2015.emdgroup.com/sites/default/files/downloads/emd/Merck_GB2015_EN.pdf
  191. ^ http://ar2014.merckgroup.com/sites/default/files/downloads/en/Merck_GB2014_EN.pdf
  192. ^ http://investors.danaher.com/image/1Q2020+Danaher+Earnings+Presentation.pdf
  193. ^ http://investors.danaher.com/image/4Q2019+Danaher+Earnings+Presentation.pdf
  194. ^ http://investors.danaher.com/download/Danaher_Annual_Report_2018.pdf
  195. ^ http://investors.danaher.com/download/danaher_2017_annualreport.pdf
  196. ^ http://investors.danaher.com/download/Danaher_2016+Annual+Report.pdf
  197. ^ http://investors.danaher.com/download/2015+Danaher+Annual+Report.pdf
  198. ^ http://investors.danaher.com/download/DHR_AR_2014.pdf
  199. ^ http://investors.danaher.com/download/DHR_AR_2013.pdf
  200. ^ http://investors.danaher.com/download/DHR_AR_2012.pdf
  201. ^ http://investors.danaher.com/download/DHR_AR_2011.pdf
  202. ^ https://www.biospace.com/article/releases/teva-reports-second-quarter-2020-financial-results/?s=72
  203. ^ https://www.biospace.com/article/releases/teva-reports-fourth-quarter-and-full-year-2019-financial-results/?s=72
  204. ^ https://s24.q4cdn.com/720828402/files/doc_downloads/doc_financial/2018/q4/Teva-Form-10-K-2018.pdf
  205. ^ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results".
  206. ^ http://www.tevapharm.com/news/teva_reports_full_year_and_fourth_quarter_2016_financial_results_02_17.aspx
  207. ^ http://www.tevapharm.com/news/teva_reports_full_year_2015_and_fourth_quarter_financial_results_02_16.aspx
  208. ^ "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
  209. ^ http://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2013_results_02_14.aspx
  210. ^ "Teva Reports Fourth Quarter and Full Year 2012 Results". tevapharm.com.
  211. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTI2NDkwfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  212. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/da090e332ffb5df3/7b2f322f2d6e/Q3_FY2020_SHL_Quarterly-Statement.pdf
  213. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/c0b555cf8faef9d4/0e0d821eefe6/H1_FY2020_SHL_Half-year-financial-report.pdf
  214. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000006835562/12e08501046c/Siemens-Healthineers-Annual-Report-2019.pdf
  215. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000005904947/ef806566e5ee/Annual-Report-2018.pdf
  216. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
  217. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
  218. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
  219. ^ https://www.biospace.com/article/releases/stryker-reports-second-quarter-2020-operating-results/?s=72
  220. ^ https://investors.stryker.com/press-releases/news-details/2020/Stryker-reports-2019-results-and-2020-outlook/default.aspx
  221. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2018/Stryker_Annual_Report_2018.pdf
  222. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2016/STRYKER-2016-AR.pdf
  223. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2014/SYK_AR-14_4_29_15-FINAL.pdf
  224. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2012/SYK-2012-AR_-03-14-13-FINAL_Single-Pages.pdf
  225. ^ http://investors.biogen.com/static-files/60eda571-f103-42ee-8b03-5c64571dfc13
  226. ^ https://investors.biogen.com/static-files/ce31eed8-8862-4bec-a63f-77c0fd6e15a1
  227. ^ http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e
  228. ^ "Biogen's Spinraza: Great Launch, Rough Ride". 25 January 2018 – via www.bloomberg.com.
  229. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2016_on_Form_10K.pdf
  230. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2015_on_Form_10K.pdf
  231. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_2014_Annual_Report_Web.pdf
  232. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2013.pdf
  233. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2012.pdf
  234. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/2011ar.pdf
  235. ^ https://sw4503.swcms.net/en/ir-library/business-results/inframe/main/010/teaserItems1/00/linkList/0/link/4q2019_en_v1.pdf
  236. ^ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.
  237. ^ https://www.biospace.com/article/releases/labcorp-announces-2020-second-quarter-results/?s=72
  238. ^ https://ir.labcorp.com/static-files/753d1464-9421-43f1-be83-d5e0be586800
  239. ^ a b c d e http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDE2OTE0fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636873221632383468
  240. ^ a b c http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjI4ODI1fENoaWxkSUQ9LTF8VHlwZT0z&t=1
  241. ^ https://www.biospace.com/article/releases/mylan-reports-strong-second-quarter-and-first-half-2020-results-and-updates-2020-guidance/?s=72
  242. ^ https://investor.mylan.com/static-files/34953fa9-6a40-48e5-8ca2-72382b1fa340
  243. ^ a b c d e http://investor.mylan.com/static-files/ed066de0-8491-4327-a044-9bb136d5b8c3
  244. ^ a b c http://investor.mylan.com/static-files/29cc2678-5735-461a-9972-6ac01dfce6c4
  245. ^ https://www.biospace.com/article/releases/baxter-reports-second-quarter-2020-results/?s=72
  246. ^ http://d18rn0p25nwr6d.cloudfront.net/CIK-0000010456/c8c941c6-2b54-474e-9ffd-e4be95a75a58.pdf
  247. ^ a b https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2018/q4/Q4-2018-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
  248. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2017/q4/Q4-2017-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
  249. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2016/q4/Q4-2016-Financial-Schedules.pdf
  250. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2015/q4/Q4-2015-Financial-Schedules.pdf
  251. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2014/q4/Q4-2014-FINAL-Financial-Schedules.pdf
  252. ^ a b https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2012/Reclassified-Sales-Final.pdf
  253. ^ a b https://www.biospace.com/article/releases/boston-scientific-announces-results-for-fourth-quarter-and-full-year-2019/?s=72
  254. ^ http://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR/annual-reports-proxy-statements/2017-performance-report.pdf
  255. ^ http://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR/annual-reports-proxy-statements/BostonScientificFinalAR2016a.pdf
  256. ^ http://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR/annual-reports-proxy-statements/BostonScientificFinalComplete.pdf
  257. ^ http://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR/annual-reports-proxy-statements/Boston-Scientific-2014-Annual-Report-and-10-K.PDF
  258. ^ http://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR/annual-reports-proxy-statements/BSXCombined-AR-and-10K.PDF
  259. ^ http://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR/annual-reports-proxy-statements/BSX-2012-AR-plus-10K.pdf
  260. ^ http://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR/annual-reports-proxy-statements/BSX-2011-AR.PDF
Retrieved from "http://en.wiki.x.io/w/index.php?title=List_of_largest_biomedical_companies_by_revenue&oldid=972221768"